comparemela.com
Home
Live Updates
Toho Holdings - Breaking News
Pages:
2
3
4
5
6
7
8
Toho Holdings News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Toho : Our view on proxy voting recommendations made by ISS(191 KB)
June 14, 2023 To whom it may. | June 15, 2023
Takeo matsutani
Atsushi udoh
Makoto kawamura
Company name
Meeting of shareholders the company
Japan fair trade commission on
Toho pharmaceutical co ltd
Toho holdings co ltd
Kyushu toho co ltd
Fair trade commission
Company view
Commission on
Supervisory committee
Relations division
Elimination regulations
Group compliance
Blackstone said to be weighing exit options for Japan-based Ayumi Pharmaceutical
The specialty pharmaceutical company is reportedly worth at least $1b.
Ayumi pharmaceutical holdings co ltd
Toho holdings co ltd
Hisamitsu pharmaceutical co inc
Takeda pharmaceutical co
Toho holdings
Ayumi pharmaceutical corp
Japan based ayumi pharmaceutical corp
Ayumi pharmaceutical
Unison capital
Hisamitsu pharmaceutical
Takeda consumer healthcare
Takeda pharmaceutical
New york headquartered
Blackstone Reportedly Weighing Options for $1B Ayumi Pharma
Ayumi was founded in 2015 and focuses on treatments for rheumatism and orthopedics.
Santen pharmaceutical co
Blackstone inc
Takeda pharmaceutical co
Showa yakuhin kako co
Ayumi pharmaceutical corp
Toho holdings co
Tokyo based ayumi
New york based
Santen pharmaceutical
Showa yakuhin kako
Unison capital
Toho holdings
Takeda pharmaceutical
Cellusion Raises 1 1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy | DNA RNA and Cells
Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
Toho holding
Ministry of health
Health sciences council
Toyo seikan group holdings
Keio innovation initiative
Keio university
Icellusion inc
Keio university hospital
Toho holdings
University of tokyo edge capital partners
Cellusion raises
Advance japan
Global clinical trials
Corneal endothelial cell regenerative therapy
Japani january
Corneal endothelial cell substitute
Clinical trial for Aevice Health s wearable respiratory monitor underway
The NUHS will facilitate the study on AeviceMD's use in detecting wheezing among paediatric patients with breathing difficulties.
National university hospital
Singapore general
National university health system
Toho holdings
Centre for innovation
Aevice health
National university
Michael lim
Enterprise singapore
vimarsana © 2020. All Rights Reserved.